Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI + Avastin + Cetuximab in mCRC
NCT00577109Phase 2Withdrawn
- Sponsor
- Roche
- Start
- Dec 2007
- Primary completion
- Jun 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, KL-140 in metastatic colorectal cancer (mCRC), sponsored by Roche. Planned start Dec 2007; status: withdrawn.
02
Drugs
bevacizumabKL-140
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00577109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577109.